Cargando...
RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy
BACKGROUND: To establish a novel delivery system of RGD-conjugated resveratrol human serum albumin (HAS) nanoparticles in ovarian cancer therapy. METHODS: The nanoparticles system was characterized for physicochemical properties, the stability in the serum and in vitro release. The comparison betwee...
Gardado en:
| Publicado en: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779302/ https://ncbi.nlm.nih.gov/pubmed/33408463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S248950 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|